• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CEO Roundtable on Cancer names Bradway chairman

CEO Roundtable on Cancer names Bradway chairman

December 7, 2015
CenterWatch Staff

The CEO Roundtable on Cancer elected Robert Bradway as its chairman at its recent annual meeting, CEO Roundtable-XIV. Bradway, chairman and chief executive officer of Amgen, will serve a three-year term.

The CEO Roundtable on Cancer, a nonprofit organization of executives, was founded by former President George H.W. Bush in 2001 with a mandate to bring bold and imaginative solutions to cancer treatment and prevention. The CEO-led effort has benefitted from a 14-year legacy of strong leadership, beginning with Bush’s appointments of former Chairs Robert Ingram, William Weldon and Christopher Viehbacher.

“The CEO Roundtable on Cancer is committed to the elimination of cancer as a public health issue,” said Bradway. “Our hope is that through powerful initiatives like the CEO Cancer Gold Standard accreditation and Project Data Sphere, we can facilitate better access to the best-available treatments, advance research and enhance prevention efforts.”

The CEO Roundtable on Cancer has led efforts in both global health and research innovation, as well as its deep commitment to employee wellness through its CEO Cancer Gold Standard workplace accreditation program. The Gold Standard recognizes employers’ efforts to build a culture of wellness by promoting healthy lifestyle choices, encouraging cancer screening and promoting access to quality cancer treatment.

Globally, CEOs from many industries are keenly aware of the life-improving impact they can have on both health and controlling healthcare costs when they address cancer and other chronic diseases. In 2012, under the chairmanship of Viehbacher, the CEO Roundtable on Cancer began working in China with government, industry and international cancer experts to bring the benefits of the Gold Standard to the world’s most populated country.

Organizations that have provided clinical trial data to the digital library-laboratory include Amgen, AstraZeneca, Bayer, Celgene, EMD Serono, Johnson & Johnson, Eli Lilly, Memorial Sloan-Kettering Cancer Center, Pfizer, Synta, Sanofi and The Alliance for Clinical Trials in Oncology, one of the five U.S. network groups of the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN).

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing